NDC Product Labeler Qilu Pharmaceutical Co. Ltd.

Qilu Pharmaceutical Co. Ltd. labeler's code is 67184. The labeler has 61 products that have an assigned National Drug Code.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Product Type	Status
67184-0501	Oxaliplatin	Oxaliplatin	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0502	Oxaliplatin	Oxaliplatin	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0503	Pemetrexed	Pemetrexed Disodium	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0504	Pemetrexed	Pemetrexed Disodium	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0507	Ondansetron	Ondansetron	Injection, Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-0508	Oxaliplatin	Oxaliplatin	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0509	Oxaliplatin	Oxaliplatin	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0510	Oxaliplatin	Oxaliplatin	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0511	Irinotecan Hydrochloride	Irinotecan Hydrochloride	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0512	Irinotecan Hydrochloride	Irinotecan Hydrochloride	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0513	Irinotecan Hydrochloride	Irinotecan Hydrochloride	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0514	Palonosetron	Palonosetron Hydrochloride	Injection	Intravenous	Human Prescription Drug	ACTIVE
67184-0515	Palonosetron	Palonosetron Hydrochloride	Injection	Intravenous	Human Prescription Drug	ACTIVE
67184-0517	Solifenacin Succinate	Solifenacin Succinate Tablets	Tablet, Film Coated	Oral	Human Prescription Drug	ACTIVE
67184-0523	Tadalafil	Tadalafil	Tablet, Film Coated	Oral	Human Prescription Drug	ACTIVE
67184-0524	Tadalafil	Tadalafil	Tablet, Film Coated	Oral	Human Prescription Drug	ACTIVE
67184-0525	Tadalafil	Tadalafil	Tablet, Film Coated	Oral	Human Prescription Drug	ACTIVE
67184-0526	Tadalafil	Tadalafil	Tablet, Film Coated	Oral	Human Prescription Drug	ACTIVE
67184-0530	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Human Prescription Drug	ACTIVE
67184-0531	Gefitinib	Gefitinib	Tablet, Coated	Oral	Human Prescription Drug	ACTIVE
67184-0532	Imatinib Mesylate	Imatinib Mesylate	Tablet	Oral	Human Prescription Drug	ACTIVE
67184-0533	Imatinib Mesylate	Imatinib Mesylate	Tablet	Oral	Human Prescription Drug	ACTIVE
67184-0535	Decitabine	Decitabine	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0540	Fosaprepitant Dimeglumine	Fosaprepitant Dimeglumine	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0549	Daptomycin	Daptomycin	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0561	Olanzapine	Olanzapine	Tablet	Oral	Human Prescription Drug	ACTIVE
67184-0562	Olanzapine	Olanzapine	Tablet	Oral	Human Prescription Drug	ACTIVE
67184-0563	Olanzapine	Olanzapine	Tablet	Oral	Human Prescription Drug	ACTIVE
67184-0564	Olanzapine	Olanzapine	Tablet	Oral	Human Prescription Drug	ACTIVE
67184-0565	Olanzapine	Olanzapine	Tablet	Oral	Human Prescription Drug	ACTIVE
67184-0566	Olanzapine	Olanzapine	Tablet	Oral	Human Prescription Drug	ACTIVE
67184-0569	Amikacin Sulfate	Amikacin Sulfate	Injection, Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-0570	Amikacin Sulfate	Amikacin Sulfate	Injection, Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-0571	Mirabegron	Mirabegron	Tablet, Film Coated, Extended Release	Oral	Human Prescription Drug	ACTIVE
67184-0572	Mirabgeorn	Mirabegron	Tablet, Film Coated, Extended Release	Oral	Human Prescription Drug	ACTIVE
67184-0573	Olanzapine	Olanzapine	Injection, Powder, For Solution	Intramuscular	Human Prescription Drug	ACTIVE
67184-0574	Ganirelix Acetate	Ganirelix Acetate	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
67184-0582	Icosapent Ethyl	Icosapent Ethyl	Capsule	Oral	Human Prescription Drug	ACTIVE
67184-0589	Micafungin	Micafungin	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0590	Micafungin	Micafungin	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0593	Bumetanide	Bumetanide	Injection	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-0594	Bumetanide	Bumetanide	Injection	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-0605	Cetrorelix Acetate	Cetrorelix Acetate For Injection	Kit	Subcutaneous	Human Prescription Drug	ACTIVE
67184-0607	Hydroxyurea	Hydroxyurea	Capsule	Oral	Human Prescription Drug	ACTIVE
67184-0611	Nicardipine Hydrochloride	Nicardipine Hydrochloride	Injection, Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-0618	Melphalan Hydrochloride	Melphalan Hydrochloride	Kit	Intravenous	Human Prescription Drug	ACTIVE
67184-1001	Cefazolin	Cefazolin	Injection, Powder, For Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-1002	Cefepime	Cefepime Hydrochloride	Injection, Powder, For Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-1003	Cefepime	Cefepime Hydrochloride	Injection, Powder, For Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-1004	Cefepime	Cefepime Hydrochloride	Injection, Powder, For Solution	Intravenous	Human Prescription Drug	ACTIVE
67184-1005	Ceftriaxone Sodium	Ceftriaxone Sodium	Injection, Powder, For Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-1006	Ceftriaxone Sodium	Ceftriaxone Sodium	Injection, Powder, For Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-1007	Ceftriaxone Sodium	Ceftriaxone Sodium	Injection, Powder, For Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-1008	Ceftriaxone Sodium	Ceftriaxone Sodium	Injection, Powder, For Solution	Intramuscular; Intravenous	Human Prescription Drug	ACTIVE
67184-0551	Ertapenem
67184-0552	Meropenem
67184-0553	Meropenem
67184-0560	Cefazolin					INACTIVATED
67184-0007		Oxaliplatin	Powder		Bulk Ingredient	UNFINISHED
67184-0013		Palonosetron Hydrochloride	Powder		Bulk Ingredient	UNFINISHED
67184-0026		Bortezomib	Powder		Bulk Ingredient	UNFINISHED